🇺🇸

Distress Insolvency

US SEC Filing Intelligence · 205 digests

· daily

US Corporate Distress Financial Stress SEC Filings — October 30, 2026

A dense cluster of eight listing-standard deficiency notices filed within a single week (Oct 26-30, 2026) signals a broad-based microcap distress wave: five companies (Alset, Actuate, Neumora, Bridger Aerospace, and effectively Banzai) breached the $1.00 minimum bid price rule, while three (Accendra/Owens & Minor, Annovis Bio, Cyngn) face market-cap, equity, or governance-based deficiencies. The dominant theme is the reverse-stock-split playbook — Alset, Neumora, and Bridger all explicitly flagged splits as cure mechanisms, and Banzai paired its delisting notice with a same-day charter amendment to 850 million authorized shares, a classic recapitalization precursor. Balance-sheet severity varies widely: Annovis disclosed a stockholders' equity deficit of ~$(4.3) million against a $48.4 million market cap (just 3.2% below the $50 million NYSE threshold), whereas Accendra faces the more onerous NYSE 802.01B business-plan process with 18-month cure and quarterly monitoring. Actuate Therapeutics is the standout outlier with two concurrent Nasdaq deficiencies (bid price plus MVLS, the latter due January 11, 2027), creating a compressed dual-deadline risk profile. Notably, no filing disclosed insider buying, dividends, buybacks, or going-concern language — capital allocation is uniformly defensive, with equity issuance/dilution the only lever in play. The April 26, 2027 bid-price cure deadline is now a synchronized catalyst date across at least four names, setting up a Q1 2027 window of split announcements, potential delistings, and forced-selling dynamics.

9 high priority 9 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 29, 2026

The five filings present a bifurcated distress landscape: three companies face imminent Nasdaq delisting (Propanc, Glucotrack, Pelican/Greenland) due to bid-price and board-independence failures, while two others (Cullen/Frost, Cloopen) execute strategic listing changes or go-private transactions. The common thread is exchange-listing risk, with Propanc and Glucotrack facing trading suspensions within days (Oct 30 and Nov 2, respectively), creating acute liquidity and capital-access threats. Cullen/Frost's voluntary NYSE-to-TXSE transfer is a notable outlier—a proactive, board-authorized move rather than a distress signal—highlighting a potential trend of Texas-based firms seeking regional exchange affiliation. Cloopen's completed merger and Form 15 filing marks the end of its public life, with dissenting shareholders now limited to Cayman Islands appraisal rights. Overall, the filings underscore a harsh environment for small-cap biotechs and micro-caps reliant on Nasdaq listing standards, with limited near-term catalysts for recovery.

5 high priority 5 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 28, 2026

Both filings in this window are Nasdaq listing-compliance events rather than bankruptcy or going-concern filings, which places them squarely within the stream's Delisting scope. Milestone Pharmaceuticals received a deficiency notice after 30 consecutive business days below $1.00, with a 180-day cure window to April 21, 2027, so the immediate listing impact is nil but the path to a reverse split or Capital Market transfer is open. OSR Health is further along the distress curve: Nasdaq's Hearings Panel denied continued listing on October 23, 2026, after a trading suspension already in place since August 26, 2026, and the stock now trades OTC while the company remains SEC-reporting. The enriched data for these filings does not include period-over-period financial comparisons, forward guidance, insider transactions, or capital allocation changes, so the analysis rests on the filing narratives and deal terms rather than quantified trend data. The common thread is sub-$1 equity pricing forcing exchange-level remediation, and OSR's $15M VXM01 put settlement via convertible notes at $2.00 to $5.00 per share signals dilution-driven funding under stress. The dated catalysts are OSR's promised update by November 6, 2026 and Milestone's April 21, 2027 cure deadline.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 27, 2026

Four of the five filings (Rekor Systems, Advasa Holdings, NextNRG, Socket Mobile) are Nasdaq listing-compliance events tied to sub-$1.00 bid prices or stockholders' equity and market value shortfalls, forming a clear cluster of small-cap distress on Nasdaq. NextNRG is the most acute case: it fails bid price, MVLS, and stockholders' equity tests, was ineligible for a second compliance period, and awaits a Hearings Panel decision with no assurance of continued listing. Socket Mobile is voluntarily migrating to the OTCID Market (last Nasdaq day expected November 18, 2026), a move that typically reduces liquidity and institutional ownership. Rekor received a 180-day extension to April 26, 2027, and Advasa has until April 19, 2027, both deadlines that fall in the same spring window and could produce a concentrated wave of reverse-split or delisting events. General Motors' 8-K contains only bylaw amendments (effective November 17, 2026) with no financial data, so it is low-materiality for this distress stream. The filings do not disclose period-over-period financials, insider transactions, or capital allocation, so quantitative trend analysis is limited; the intelligence is primarily about listing status and timing.

5 high priority 5 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 26, 2026

Four 8-K filings dated around October 21-26, 2026 were reviewed for the USA Corporate Distress & Bankruptcy stream. Getty Images Holdings, Inc. is the clearest distress event, having filed Chapter 11 petitions in Delaware on October 21, 2026 and secured up to $143 million in DIP financing from Cantor Fitzgerald, with adequate protection payments flowing to prepetition secured lenders. Elme Communities is in an orderly wind-down rather than a bankruptcy: its NYSE delisting is tied to a Plan of Sale and Liquidation, with remaining assets moving to a Liquidating Trust and a Board retaining the right to terminate the plan. Zeo Energy and Eve Holding are listing-compliance events rather than insolvency signals. Zeo received a 180-day extension to April 19, 2027 to cure its $1.00 minimum bid price deficiency, and Eve Holding's NYSE warrant delisting reflects an abnormally low selling price on EVEXW while the common stock (EVEX) continues trading. The filings supplied do not contain period-over-period financial comparisons, insider transaction data, or quantified guidance, so trend analysis is limited to what the narrative discloses. The shared theme is that the stream's scope (bankruptcy, going concern, delisting) is captured most directly by Getty and Elme, with Zeo and Eve representing earlier-stage distress markers.

4 high priority 4 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 26, 2026

This USA Bankruptcy & Insolvency stream contains a single in-scope filing: Getty Images Holdings, Inc.'s 8-K disclosing voluntary Chapter 11 petitions filed October 21, 2026 in the U.S. Bankruptcy Court for the District of Delaware, alongside a DIP credit agreement dated October 23, 2026 with Cantor Fitzgerald Securities as administrative and collateral agent providing up to $143 million in new financing. With only one filing, cross-company period-over-period comparisons and sector-level aggregation are not meaningful; the excerpt also discloses no positive operating metrics, guidance, or insider activity. The dominant market implication is a distressed capital structure in which prepetition secured lenders, including Koch Equity Development LLC and its related parties on the prepetition EUR Term Loan, are receiving adequate protection payments while DIP liens and carve-out provisions reorder recovery priority. Equity and junior creditor recoveries appear at high risk, and the filing's 9/10 materiality reflects the scale of the restructuring event rather than any verifiable improvement in operations.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 23, 2026

All nine filings in this stream point to a concentrated wave of Nasdaq and NYSE listing-compliance distress rather than bankruptcy, going-concern, or delisting-completed events in the strict sense. Three distinct failure modes dominate: stockholders' equity deficiencies (Lunai Bioworks, Dragonfly Energy, STEM, Polar Power), minimum bid price breaches (Akebia, Laser Photonics, Medicus Pharma, Innventure), and market-value-of-listed-securities shortfalls (Century Casinos). Lunai Bioworks is the most advanced distress case, having reported a $(9.0)M stockholders' deficit and voluntarily chosen delisting with trading suspension on October 30, 2026 and no planned OTC quotation. Dragonfly's deficit is much smaller at $(184,000) but it has a hard December 31, 2026 evidence deadline. Polar Power illustrates the cure-by-financing pattern: an estimated $2.9M pro forma equity was largely produced by insider and related-party conversions and dilutive PIK-bearing preferred paper, so the compliance is fragile. Medicus Pharma regained bid-price compliance on October 23, 2026 after ten days above $1.00 following a delisting determination, showing that short-term price recovery can moot delisting. Because the enriched period-over-period, insider, capital allocation, and forward-looking fields were not populated for these filings, quantitative trend comparisons across companies are not available; the analysis below relies on the stated filing facts and dates.

9 high priority 9 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 22, 2026

This distress stream covers four 8-K filings dated around October 2026, all in scope for bankruptcy, going-concern, or delisting events. Leslie's is the most severe case: a pre-arranged Chapter 11 with an RSA, a disclosure statement and plan filed October 20, 2026, Nasdaq delisting, and an explicit warning that equity holders may be significantly impaired. Atlantic American (AAME) faces a Nasdaq delisting determination for missed 10-K/10-Q filings, with a Hearings Panel request due October 23, 2026. SenesTech (SNES) has a sub-$1 bid-price deficiency with a compliance deadline of April 19, 2027, a lower-urgency but still negative signal. Alaunos Therapeutics is the one filing showing a potential reversal: it claims to have regained the $2.5M stockholders' equity requirement after a merger and a roughly $350M private placement, though the outcome hinges on Nasdaq Staff confirmation before the November 10, 2026 Panel hearing. The filings provide no period-over-period financial figures, insider transactions, or capital allocation data, so quantitative trend comparisons are not possible; the analysis rests on listing-status events and restructuring milestones.

4 high priority 4 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 22, 2026

The USA Bankruptcy & Insolvency stream for the period 2026-10-22 contains a single in-scope filing: Leslie's, Inc.'s 8-K disclosing its pre-arranged Chapter 11 filing (Southern District of Texas, Case No. 26-90795) backed by a restructuring support agreement with term loan lenders. The company and nine subsidiaries filed on September 30, 2026, and on October 20, 2026 filed a disclosure statement and joint plan of reorganization consistent with the RSA. Nasdaq delisted the common stock, which has traded on the Pink Limited Market as LESLQ since October 6, 2026, and management explicitly warns that equity holders may suffer a significant or total loss if the plan is confirmed. The filing carries maximum materiality (10/10) and negative sentiment. Because the enriched period-over-period, insider, capital allocation, and forward-looking fields are not populated for this single filing, cross-company trend analysis and quantitative comparisons are not possible; the portfolio-level read is that the dominant development is a lender-driven, pre-negotiated restructuring that prices equity as a likely wipeout. The actionable focus is on plan confirmation milestones and the treatment of existing equity under the joint plan.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 21, 2026

Both filings in this stream's window are in scope and both are distress events: Getty Images filed a prepackaged chapter 11 (Oct 21, 2026) to implement a restructuring support agreement signed Oct 12, cancelling all Class A common stock and equity interests with no recovery while accelerating roughly $1.0 billion of term loans, revolver and senior notes; Direct Digital Holdings is voluntarily withdrawing its Class A stock from Nasdaq after a Oct 1 delist determination under Listing Rule 5550(b)(1) and a trading suspension since Oct 5, citing going-concern doubt and credit-facility covenant risk. The common theme is equity holders bearing the full cost of balance-sheet distress, with both names migrating to OTC Pink. The enriched period-over-period, insider, capital-allocation and guidance fields were not populated for either filing, so no quantitative YoY/QoQ trend, insider-pattern or forward-guidance claims can be made from this data set. Market implication: equity is effectively being wiped out in the Getty plan and is at high risk of similar treatment at Direct Digital, while creditors are the operative stakeholders; near-term price action should be treated as liquidity-driven rather than fundamentals-driven.

2 high priority 2 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 21, 2026

This session contained only one filing, Getty Images Holdings, Inc.'s 8-K announcing a voluntary prepackaged Chapter 11 filing on October 21, 2026 in the District of Delaware, backed by a restructuring support agreement signed October 12, 2026. The filing is squarely within the stream's Chapter 11 and bankruptcy focus, and it carries maximum materiality (10/10) with negative sentiment. The plan wipes out all Class A common stock and equity interests, including those held by majority shareholders, with no recovery, while general unsecured claims are unimpaired, which signals a creditor-led recapitalization. Acceleration of roughly $1.0 billion across term loans, revolving loans and three senior note issues means the debt stack is being restructured rather than serviced on existing terms. Because the filing contains no period-over-period financial comparisons, insider transaction data, or forward-looking guidance in the enriched fields provided, cross-company trend analysis is not possible this cycle. The market implication is near-total equity loss with a delisting from the NYSE to OTC Pink, and the main investable question is the timing and terms of plan confirmation.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 20, 2026

Four filings were reviewed for the USA Corporate Distress & Bankruptcy stream, but only three fall within its scope of Bankruptcy, Going Concern, and Delisting events. Those three are a Nasdaq delisting or listing-deficiency cluster: Lottery.com (SEGG) faces suspension on October 23, 2026 over a delinquent Q2 2026 10-Q, SHF Holdings received a bid-price extension to April 19, 2027, and XWELL received a bid-price deficiency notice with a compliance deadline of April 5, 2027. Hilton's voluntary NYSE-to-Nasdaq transfer is not a distress event and is excluded. The enriched data in the filings does not include period-over-period financial comparisons, insider transactions, capital allocation details, or financial ratios, so cross-company quantitative trend analysis is not possible; the analysis rests on listing-compliance timelines and filing-status facts. The most time-critical item is Lottery.com's October 21 hearing-request deadline ahead of the October 23 suspension, while the two bid-price cases share a structure that points to likely reverse stock splits in the coming months. Common pattern: all three in-scope companies are small-cap Nasdaq issuers struggling with either filing discipline or share price.

4 high priority 4 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 19, 2026

Both filings in this distress-focused stream point to acute stress among small-cap US issuers, though the severity differs sharply. Stardust Power (SDST) has crossed a hard Nasdaq trigger: its stock closed at $0.10 or less for ten consecutive trading days, leading to suspension and delisting of both common stock and warrants at the open on October 23, 2026, with a hearing request (fee $20,000, deadline 4:00 p.m. ET, October 23) that will not stay the suspension. Its CFO has resigned effective the same date, and the board is weighing headcount cuts, possible suspension of SEC reporting, and a sale or merger, with no assurance of any outcome. Scienture Holdings reported preliminary unaudited Q3 2026 revenue of about $1.22 million, up 256% sequentially from roughly $344,000 in Q2, on the August 2026 REZENOPY launch and Arbli wholesale unit growth of 74% sequentially, but its own risk factors flag going-concern doubt, dilution, lender security interests, and Nasdaq listing risk. The portfolio pattern is a steep sequential revenue inflection at a company that still lacks audited results and profitability, versus an outright exchange-driven delisting at another. Because the Scienture figures are unaudited and subject to adjustment in the 10-Q, the growth story should be discounted until verified. The key near-term market event is the October 23 Stardust delisting cascade, which is largely determined by the exchange rule rather than management action.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 16, 2026

This batch of 10 filings is dominated by listing-compliance and distress signals rather than operating performance: seven of ten filings concern Nasdaq or NYSE deficiency notices, voluntary delisting, or delisting processes (Bridgeline Digital, Aether Holdings, CALLAN JMB, eHealth, Lucid Diagnostics, Health In Tech, Canopy Growth), while the remaining filings cover a voluntary NYSE delisting (SITE Centers), an undisclosed-reason NYSE delisting (Apollo Commercial Real Estate Finance), and a completed Chapter 11 emergence (Cumulus Media). The filings do not contain period-over-period financial comparisons, forward guidance figures, insider transaction data, or capital allocation metrics, so quantitative trend analysis is not possible from this batch; the analysis below relies on dates, thresholds, and deadlines stated in the filings. The most acute situation is CALLAN JMB, which faces a trading suspension on October 21, 2026 absent a successful Nasdaq Hearings Panel outcome after failing a $2.5M stockholders' equity requirement. A recurring theme is the April 12, 2027 Nasdaq bid-price compliance deadline shared by four companies, which will likely produce a cluster of reverse-split proposals and listing-transfer decisions. Cumulus Media's emergence, eliminating roughly $550M to $600M of debt, is the single most material restructuring outcome, though it removes the public equity instrument from the stream's view.

10 high priority 10 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 16, 2026

This quiet session contains a single in-scope filing: Cumulus Media's 8-K announcing completion of its prepackaged Chapter 11 restructuring, filed March 4, 2026 in the Southern District of Texas. The plan canceled roughly $600 million of funded debt in exchange for 100% of reorganized equity and $50 million of new convertible notes issued to former lenders, with the release citing $550 million of debt eliminated. The company is now privately owned, ending its public listing under CMLS, appointed a new Board, retained management, and amended its ABL revolver to maintain liquidity. Period-over-period operating metrics, forward guidance, insider activity, and capital allocation data were not quantified in the release, so cross-filing trend analysis is not possible from this session. The market implication is that the equity of the former public company is effectively extinguished for public holders, while the deleveraged private entity's post-emergence performance will be opaque absent future disclosures. With a single filing, no sector-wide pattern can be asserted.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 15, 2026

All three filings in this stream are Nasdaq minimum-bid-price or creditor-process disclosures, and together they paint a picture of late-stage distress concentrated in micro-cap, low-priced equities. Innovative Eyewear (LUCY) and Cyngn (CYN) both received Nasdaq Rule 5550(a)(2) deficiency notices after 30 consecutive business days below $1.00, with compliance windows ending April 7, 2027 and April 12, 2027 respectively, so near-term delisting risk is not imminent but both stocks face a reverse-split decision within roughly six months. Greenlane Holdings (GNLN) is the most severe case: four operating subsidiaries executed Florida Chapter 727 assignments for the benefit of creditors on September 30, 2026, with Miami-Dade Circuit Court jurisdiction assumed October 9, 2026, meaning an assignee is liquidating assets for creditors, and the filing flags potential claims against the parent or remaining subsidiaries. The filings provided do not include period-over-period financial comparisons, insider transaction data, capital allocation details, or forward guidance, so quantitative trend analysis is limited to what the notices themselves state. The portfolio-level pattern is clear: sub-$1 equity, dilution-prone capital structures, and a reverse split as the common cure path.

3 high priority 3 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — October 15, 2026

This digest covers a single enriched filing in the USA Bankruptcy & Insolvency stream: an 8-K from Greenlane Holdings, Inc. (GNLN) disclosing that four subsidiaries executed Florida Chapter 727 assignments for the benefit of creditors on September 30, 2026, with court jurisdiction assumed by the Miami-Dade Circuit Court on October 9, 2026. The filing is squarely in scope (insolvency proceedings under an ABC process) and carries high materiality (8/10) and negative sentiment. No period-over-period financial comparisons, forward-looking guidance, insider transactions, or capital allocation data were provided in the enriched payload, so cross-filing trend analysis is not possible from this stream alone. The critical development is that the assignee will liquidate assets and distribute proceeds, the assignments do not discharge subsidiary liabilities, and no consolidation or judge has yet been assigned. The prior deconsolidation of these entities and the flagged potential claims against the parent or remaining subsidiaries mean the parent's equity exposure and contingent liability profile remain unresolved.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 14, 2026

Both filings in this window are Nasdaq listing-compliance disclosures, and both fall squarely within the Corporate Distress & Bankruptcy stream's delisting scope. AMASS Brands received a new Nasdaq notice for 30 consecutive business days below $1.00 (compliance deadline April 7, 2027), layered on top of a separate market value deficiency with a January 19, 2027 deadline, indicating compounding listing stress. Netcapital Inc. cured its bid-price deficiency but remains exposed to a more serious governance problem: late FY2026 10-K and Q1 FY2027 10-Q filings, prior financial statements declared unreliable for FY2022 through FY2025, auditor resignation, and a re-audit now under way with Adeptus Partners. The enriched period-over-period, insider, forward-looking, and capital-allocation fields are not populated for either filing, so quantitative trend analysis is not possible from this data; the conclusions rest on disclosed deficiencies and deadlines. The common theme is that sub-$1 trading and filing or reporting failures are the leading distress indicators for small-cap Nasdaq issuers, and both situations carry delisting risk that is only partly time-bounded.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 13, 2026

All five filings sit squarely in the stream's distress scope (Nasdaq/NYSE delisting notices, going-concern disclosure, and balance-sheet stress), and none carries the forward-looking guidance, insider-trading, or capital-allocation enrichment the brief anticipates, so the synthesis rests mainly on the stated filing facts. The dominant theme is listing-compliance distress: three of five filings (ClearOne, Newton Golf, Equus) cite exchange deficiencies, two of which (ClearOne, Newton Golf) involve the $2.5 million minimum stockholders' equity test under Nasdaq Rule 5550(b)(1), a direct signal of capital erosion. Visium Technologies shows the clearest quantified deterioration: operating cash burn widened 122% to $(913,888), cash fell 63% to $22,212, and FY net income of $856,102 was produced entirely by a $2,923,004 debt-extinguishment gain rather than operations, while ~1.27 billion shares outstanding plus ~1.32 billion potential shares signal heavy dilution. CN Healthy Food Tech is the outlier, with a Nasdaq Panel keeping it listed under a one-year monitor after a disclosure omission regarding a CSRC filing, a governance rather than solvency issue. The near-term catalyst cluster is the October 13-20, 2026 window, when hearing-request and appeal deadlines determine whether ClearOne, Newton Golf and Equus face imminent suspension.

5 high priority 5 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — October 09, 2026

All five filings in this stream are distress-related, centered on US exchange listing deficiencies rather than bankruptcy filings or going-concern opinions. The common thread is Nasdaq and NYSE/NYSE American continued-listing enforcement: three companies face sub-$1 bid-price or equity-related deficiencies (Streamex, Accendra Health), and three face governance or filing-compliance failures (Better Home & Finance, IT Tech Packaging), with Alaunos already at the delisting-hearing stage. Because the enriched period-over-period, insider, capital-allocation and forward-looking fields were not populated in these filings, quantitative trend comparisons are not available; the analysis therefore rests on the explicit deadlines, notice dates and materiality ratings disclosed. The most critical development is Alaunos Therapeutics (materiality 8/10), where the October 5, 2026 delisting notice for sub-$2.5M stockholders' equity is now proceeding to a Hearings Panel with a strategic-alternatives process that carries no assured outcome. IT Tech Packaging (8/10) and Better Home & Finance (7/10) also carry near-term enforcement risk, while Streamex and Accendra have the longest cure windows (to April 2027 and roughly April 2027 respectively). Portfolio-level, the pattern is distress manifesting as exchange compliance pressure well ahead of any insolvency event.

5 high priority 5 total filings